Islet Biology joint with Diabetes Organizer(s): Markus Stoffel, Doris A. Stoffers and Per-Olof Berggren Date: April 12 - 17, 2010
Location: Whistler Conference Centre, Whistler, BC, CanadaThis symposium will focus on advances in our understanding of normal pancreatic b-cell function and mechanisms of beta-cell failure in type 2 diabetes, which has become a pandemic disease with estimates of affected individuals reaching 350 millions in 2030. Defects in pancreatic b-cell function and reduced beta cell mass are now recognized as the event that triggers the transition from pre-diabetes/metabolic syndrome to overt type 2 diabetes. Major advances have been made in our understanding of fundamental beta-cell biology, signaling pathways regulating islet growth, apoptosis, regeneration in normal and disease states, and development of new strategies for enhancing beta-cell survival and function. Leading academic and industrial contributors alike will carefully discuss recent advances in several disciplines, including development, regeneration, stem cells, transcription factors, novel signaling pathways, cell biology, genetics, gene regulation, drug targeting, as well as emerging technologies in islet research. Scholarship Deadline: December 14 2009 Discounted Abstract Deadline: December 14 2009 Abstract Deadline: January 15 2010 Discounted Registration Deadline: February 12 2010
Michael A. Kalwat
Peter Stefan Wunderli
|